Eurozone - Spark Newswire

2 minute read

Regeneron’s and Sanofi’s Dupixent SmPC Updated With Long-term Data Reinforcing Well-established Safety Profile in Adults With Moderate-to-severe Atopic Dermatitis

Today, 1:30 PM

Long-term safety data from a study of adults with moderate-to-severe atopic dermatitis treated with Dupixent will be added to the Dupixent Summary of Product Characteristics (SmPC) following a positive opinion issued by the European Medicines Agency's Committee for Medicinal Products for Human Use.

REGN

2 minute read

Mid-Afternoon Market Update: Dow Surges 250 Points; CalAmp Shares Slide

By Lisa Levin

Today, 1:30 PM

Toward the end of trading Friday, the Dow traded up 0.76% to 34,455.02 while the NASDAQ rose 0.04% to 14,375.24. The S&P also rose, gaining 0.39% to 4,283.15.

CAMP

3 minute read

Mid-Day Market Update: Fuwei Films Jumps Following Q1 Results; Oasis Midstream Partners Shares Plunge

By Lisa Levin

Today, 1:30 PM

Midway through trading Friday, the Dow traded up 0.56% to 34,389.25 while the NASDAQ fell 0.02% to 14,366.72. The S&P also rose, gaining 0.21% to 4,275.24.

CAMP

2 minute read

Mid-Morning Market Update: Markets Mostly Higher; CarMax Tops Q1 Views

By Lisa Levin

Today, 1:30 PM

Following the market opening Friday, the Dow traded up 0.57% to 34,392.24 while the NASDAQ fell 0.06% to 14,360.84. The S&P also rose, gaining 0.20% to 4,275.16.

FFHL

2 minute read

A Peek Into The Markets: US Stock Futures Up Following Thursday’s Rally; Nike Posts Upbeat Results

By Lisa Levin

Today, 1:30 PM

Pre-open movers

5 minute read

Regeneron Pharmaceuticals and Sanofi Announced Libtayo Approved by the European Commission as the First Immunotherapy Indicated for Patients with Advanced Basal Cell Carcinoma

By Charles Gross

Today, 1:30 PM

Regeneron Pharmaceuticals, Inc.

REGN

2 minute read

Aurinia Pharmaceuticals Announced Licensing Partner Otsuka Filed Initial Marketing Authorization Application for Voclosporin with the European Medicines Agency

By Charles Gross

Today, 1:30 PM

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced today that the Company's licensing partner, Otsuka Pharmaceutical Europe Ltd. (OPEL), filed an initial Marketing Authorization Application (MAA) for voclosporin for the treatment of lupus nephritis (LN) to the European Medicines Agency (EMA).

AUPH

3 minute read

UK’s CMA to Investigate Amazon and Google over Fake Reviews

By Charles Gross

Today, 1:30 PM

The CMA has opened a formal probe into Amazon (NASDAQ: AMZN) and Google (NASDAQ: GOOG) (NASDAQ: GOOGL) over concerns that they have not been doing enough to combat fake reviews on the

AMZN

3 minute read

Mid-Afternoon Market Update: Dow Jumps Over 300 Points; Portage Biotech Shares Slide

By Lisa Levin

Today, 1:30 PM

Toward the end of trading Thursday, the Dow traded up 1.03% to 34,222.59 while the NASDAQ rose 0.74% to 14,377.16. The S&P also rose, gaining 0.67% to 4,270.15.

ACN

3 minute read

Mid-Day Market Update: Rite Aid Falls On Downbeat Sales; Marin Software Shares Gain

By Lisa Levin

Today, 1:30 PM

Midway through trading Thursday, the Dow traded up 0.85% to 34,161.06 while the NASDAQ rose 0.80% to 14,386.13. The S&P also rose, gaining 0.61% to 4,267.52.

ACN